Add BrightSurf on Google Email

Science News for July 1, 2018


Gene discovery unlocks mysteries to our immunity

A team of researchers from CSIRO Australia has identified a new gene called C6 that regulates the body's immune response to infection and disease. The discovery could lead to targeted therapies for various diseases, including cancer, diabetes, and inflammatory disorders.

SourceCSIRO Australia·JournalJournal of Biological Chemistry·DateJul 1, 2018

Predicting bad side effects

Researchers developed a DNA sequencing kit that identifies variations in the NUDT15 gene, allowing for accurate predictions of adverse reactions. The test has been approved for clinical use in Japan and holds promise for reducing severe side effects in East Asian patients.

SourceTohoku University·JournalJournal of Gastroenterology·DateJul 1, 2018

Cost-effective universal screening for hepatitis C in France

A mathematical model developed by Sylvie Deuffic-Burban assesses the efficacy and cost-effectiveness of different screening strategies, including universal screening. The results show that universal screening is associated with better life expectancy adjusted for quality of life than other strategies.

SourceANRS·JournalJournal of Hepatology·DateJul 1, 2018